- Trials with a EudraCT protocol (14)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
14 result(s) found for: Applied Psychology.
Displaying page 1 of 1.
EudraCT Number: 2010-024202-34 | Sponsor Protocol Number: 24122010 | Start Date*: 2014-04-24 | |||||||||||
Sponsor Name:UNIVERSITÄTSMEDIZIN GÖTTINGEN, GEORG-AUGUST-UNIVERSITÄT,Klinik für Kinder- und Jugendpsychiatrie/Psychotherapie | |||||||||||||
Full Title: Effect of oxytocin on therapy results of a group based social skill training in adolescents with Autism Spectrum Disorder | |||||||||||||
Medical condition: high-functioning autismus spectrum disorders: autistic disorder (F84.0), Asperger syndrome (F84.5), atypical autism (F84.1) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-003750-89 | Sponsor Protocol Number: KKS-186 | Start Date*: 2013-02-14 | |||||||||||
Sponsor Name:Philipps-University Marburg | |||||||||||||
Full Title: A placebo-controlled, double blind, randomised trial with crossover-design investigating the effect of oxytocin nasal spray on neuronal processes of empathy | |||||||||||||
Medical condition: high-functioning autism spectrum disorders: autistic disorder (F84.0), Asperger syndrome (F84.5), atypical autism (F 84.1) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-004079-38 | Sponsor Protocol Number: 01112012 | Start Date*: 2013-01-14 |
Sponsor Name:Central Institute of Mental Health, Department of Psychiatry and Psychotherapy | ||
Full Title: Agomelatine treatment of major depressive episodes in the course of schizophrenic psychoses (AGOPSYCH). A single arm, prospective pilot study | ||
Medical condition: Major depressive episode | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-004579-37 | Sponsor Protocol Number: MZ12-PCP-PalenicekTomas-A | Start Date*: 2014-06-18 |
Sponsor Name:National Institute of Mental Health | ||
Full Title: Animal and human serotonergic model of schizophrenia: validity evaluated by qEEG and fMRI | ||
Medical condition: Inclusion criteria: a) Men and women at age between 28 and 65 years b) healthy volunteers with negative psychiatric history (severe mental illnesses that meet the criteria of ICD 10 F0.X - F99.X) ... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: CZ (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002161-56 | Sponsor Protocol Number: NeM-CSM-FT-01 | Start Date*: 2017-04-13 |
Sponsor Name:Mateusz Gola | ||
Full Title: Towards the understanding of neuronal mechanisms of compulsive sexual behaviors - pharmacotherapy | ||
Medical condition: compulsive sexual behavior (hypersexual disorder) | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: PL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2012-001599-12 | Sponsor Protocol Number: 18F-AV-45-C01 | Start Date*: 2014-03-04 |
Sponsor Name:VU University Medical Center (VUmc) | ||
Full Title: The clinical value of amyloid imaging with [18F]-AV45 in a population of memory clinic patients | ||
Medical condition: The total number of inclusion in this study is 170 subjects; 140 patients (including Alzheimer’s disease (AD) patients, patients with mild cognitive impairment (MCI), patients with subjective memor... | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003676-13 | Sponsor Protocol Number: 2.1_15052022 | Start Date*: 2022-07-18 |
Sponsor Name:Medical University of Vienna | ||
Full Title: A prospective randomized, double blind, controlled, safety and non-inferiority study of esketamine plus propofol compared to methohexital anesthesia for electroconvulsive therapy | ||
Medical condition: severe uni- or bipolar depression (F32.2, F32.2, F33.2, F33.3, F31.4, F31.5) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003280-38 | Sponsor Protocol Number: PSY-NIL-0006 | Start Date*: 2016-05-04 | |||||||||||
Sponsor Name:Medical University of Vienna | |||||||||||||
Full Title: Positron Emission Tomography assessment of Ketamine Binding of the Serotonin Transporter and its Relevance for Rapid Antidepressant Response | |||||||||||||
Medical condition: 20 patients with severe unipolar depression (structured clinical interview for DSM-IV and the 17-item Hamilton Depression Rating Scale), also 20 age and sex matched healthy controls. plus 12 HC f... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-003984-24 | Sponsor Protocol Number: EPIsoDE_01 | Start Date*: 2020-11-17 |
Sponsor Name:Central Institute of Mental Health | ||
Full Title: A phase II randomized, double-blind, active placebo-controlled parallel group trial to examine the efficacy and safety of psilocybin in treatment-resistant major depression | ||
Medical condition: Treatment-Resistant Depressive Episode or Treatment-Resistant Recurrent Depressive Disorder of moderate to severe degree withoutpsychotic features | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001444-66 | Sponsor Protocol Number: VESPA | Start Date*: 2018-09-12 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA INTEGRATA VERONA | |||||||||||||
Full Title: ASSESSING TOLERABILITY AND EFFICACY OF VORTIOXETINE VERSUS SSRIs IN ELDERLY PATIENTS WITH DEPRESSION: A PRAGMATIC, MULTICENTER, OPEN-LABEL, PARALLEL-GROUP, SUPERIORITY, RANDOMIZED TRIAL | |||||||||||||
Medical condition: major depression | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-000709-36 | Sponsor Protocol Number: 15/0947 | Start Date*: 2016-11-23 | ||||||||||||||||||||||||||
Sponsor Name:UCL | ||||||||||||||||||||||||||||
Full Title: Research into Antipsychotic Discontinuation and Reduction (RADAR): A Randomised Controlled Trial | ||||||||||||||||||||||||||||
Medical condition: Schizophrenia, delusional disorders, schizoaffective disorder, psychosis | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000547-27 | Sponsor Protocol Number: CTIMPMCRENAL12 | Start Date*: 2012-11-01 | |||||||||||||||||||||
Sponsor Name:East and North Hertfordshire NHS Trust [...] | |||||||||||||||||||||||
Full Title: A Pilot Randomised Controlled Trial of Drug Treatment for Depression in Patients undergoing Haemodialysis | |||||||||||||||||||||||
Medical condition: Major Depressive Disorder in Patients with End Stage Renal Disease | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2011-000567-26 | Sponsor Protocol Number: 2010-021883-14 | Start Date*: 2013-01-31 | |||||||||||
Sponsor Name:Radboud University Medical Centre Nijmegen | |||||||||||||
Full Title: A randomized double-blind, placebo-controlled study of risperidone in the treatment of DSM-IV-TR conduct disorder in children and adolescents. | |||||||||||||
Medical condition: Conduct Disorder DSM-IV-TR; 312.8x¸ APA, 2000 | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Ongoing) GB (GB - no longer in EU/EEA) ES (Ongoing) FR (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-022638-96 | Sponsor Protocol Number: CAFQ056B2214 | Start Date*: 2011-06-15 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of AFQ056 in adolescent patients with Fragile X Syndrome | |||||||||||||
Medical condition: Fragile X Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) SE (Completed) FR (Ongoing) DK (Completed) DE (Completed) ES (Completed) Outside EU/EEA IT (Completed) BE (Completed) NL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.